-
Mashup Score: 0Pharma has over $500B in capital for deals - 18 hour(s) ago
Pharma has over $500B in capital for deals, analysts note — with companies like Novo Nordisk, Eli Lilly, and Merck continuing to be open to early-stage deals:
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Pharmalittle: We're reading about a boy dying in Pfizer trial; AstraZeneca yanking Covid shot, and more - 19 hour(s) ago
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 6
Endo “was one of the worst actors in the opioid crisis” said Andrew Kolodny of the Opioid Policy Research Collaborative at Brandeis University.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2
“For some reason in rehabilitation research, we’ve kind of lost that ethos” of centering patients, says James Sulzer on a new episode of the “First Opinion Podcast.”
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 14Making the promise of monoclonal antibody therapies available to all - 22 hour(s) ago
As Americans strive to move beyond Covid-19, it is important to acknowledge that for their 7 million immunocompromised fellow citizens the pandemic continues to be an ongoing challenge.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7Gene therapy trial targeting rare form of deafness shows ‘jaw-droppingly good’ results - 23 hour(s) ago
Two congenitally deaf children can hear after being treated with a gene therapy, according to new data from an ongoing clinical trial.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 7Apple pushes into clinical trials with new FDA nod for Apple Watch - 23 hour(s) ago
The FDA nod means trial sponsors can use Apple Watch’s A-fib history as a secondary endpoint in trials without having to do additional work.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 6
The immense potential benefits of biotechnology are profoundly vulnerable to misuse. Better screening of synthetic DNA orders is a key barrier to bad actors.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 22Young boy dies in trial for Pfizer Duchenne gene therapy - 1 day(s) ago
A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 22Young boy dies in trial for Pfizer Duchenne gene therapy - 1 day(s) ago
A boy with Duchenne muscular dystrophy died after receiving a Pfizer experimental gene therapy. The company is pausing its trial in older boys.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
Pharma has over $500B in capital for deals, analysts note — with companies like Novo Nordisk, Eli Lilly, and Merck continuing to be open to early-stage deals. https://t.co/wXxwEAeDMk